Abstract
We analyzed pancreatic endocrine tumors (PETs) from 200 patients for the incidence of multihormonality and entrapped islets and correlated the results with clinicopathological features. Our series included 86 cases (43%) of functioning PET and 114 cases (57%) of nonfunctioning PET. Classified according to the WHO classification, there were 32 well-differentiated benign PETs, 85 well-differentiated PETs with uncertain behavior, and 83 well-differentiated malignant PETs. All tumors were immunostained for pancreatic hormones (insulin, glucagon, somatostatin, and pancreatic polypeptide) and for additional hormones such as gastrin, vasoactive intestinal polypeptide, calcitonin, seratonin, and adrenocorticotropic hormone. Multihormonality was found in 34% of all PETs and it was a frequent finding in the tumors of the uncertain behavior (38.8%) group. Islet entrapment was found in 57 tumors (28.5%) and was significantly more frequent in PETs with uncertain and malignant behavior than benign ones (p=0.01). In 57 cases, we also investigated whether ductule entrapment accompanied islet entrapment. Of these 57 tumors, 45 (79%) tumors had accompanying ductule entrapment. Ductule entrapment did not show significant correlation with malignancy and was a more frequent finding in nonfunctioning tumors. We conclude that the incidence of multihormonality in PETs is not as high as suggested previously and islet entrapping may reflect aggressive tumor growth and may be a complementary criterion for predicting the biological behavior of PETs.
Similar content being viewed by others
References
Chatelain D, Parc Y, Christin-Maitre S, Parc R, Flejou JF (2002) Mixed ductal–pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology 41:122–126
Deshpande V, Selig MK, Nielsen GP, Fernandez-del Castillo C, Lauwers GY (2003) Ductulo-insular pancreatic endocrine neoplasms. Clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms. Am J Surg Pathol 27:461–468
Heitz PU, Kasper M, Polak JM, Klöppel G (1982) Pancreatic endocrine tumours. Immunohistochemical analysis of 125 tumours. Hum Pathol 13:263–271
Klöppel G (2000) Mixed exocrine–endocrine tumors of the pancreas. Semin Diagn Pathol 17:104–108
Klöppel G, In’t Veld PA, Komminoth P, Heitz PU (1998) The endocrine pancreas. In: Kovacs K, Asa SL (eds) Functional endocrine pathology, 2nd edn. Blackwell, Boston, pp 415–487
Kruseman AC, Knijnenburg G, de la Riviere GB, Bosman FT (1978) Morphology and immunohistochemically-defined endocrine function of pancreatic islet cell tumours. Histopathology 2:389–399
La Rosa S, Sessa F, Capella C, Riva C, Leone BE, Klersy C, Rindi G, Solcia E (1996) Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 429:323–333
Larsson LI, Grimelius L, Håkanson R, Rehfeld JF, Stadil F, Holst J, Angervall L, Sundler F (1975) Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol 79:271–284
Le Bodic MF, Heymann MF, Lecomte M, Berger N, Berger F, Louvel A, De Micco C, Patey M, De Mascarel A, Burtin F, Saint-Andre JP (1996) Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I. Am J Surg Pathol 20:1378–1384
Liu TH, Tseng HC, Zhu Y, Zhong SX, Chen J, Cui QC (1985) Insulinoma: an immunohistochemical and morphologic analysis of 95 cases. Cancer 56:1420–1429
Liu TH, Zhu Y, Cui QC, Cai LX, Ye SF, Zhong SX, Jia HP (1992) Nonfunctioning pancreatic endocrine tumors. An immunohistochemical and electron microscopic analysis of 26 cases. Pathol Res Pract 188:191–198
Mukai K, Greider MH, Grotting JC, Rosai J (1982) Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 6:387–399
Ohike N, Jürgensen A, Pipeleers-Marichal M, Klöppel G (2003) Mixed ductal–endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 442:258–265
Ohike N, Kosmahl M, Klöppel G (2004) Mixed acinar–endocrine carcinoma of the pancreas: a clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 445:231–235
Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, Iacono C, Serio G, Zamboni G (1996) Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 27:1124–1134
Reid JD, Yuh SL, Petrelli M, Jaffe R (1982) Ductuloinsular tumors of the pancreas: a light, electron microscopic and immunohistochemical study. Cancer 49:908–915
Sipos B, Möser S, Kalthoff H, Török V, Löhr M, Klöppel G (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 442:444–452
Solcia E, Capella C, Buffa R, Usellini L, Fiocca R, Sessa F, Tortora O (1984) The contribution of immunohistochemistry to the diagnosis of neuroendocrine tumors. Semin Diagn Pathol 1:285–296
De Lellis RA, Lloyd RV, Heitz PU, Eng C (2004) Pathology and genetics of tumours of endocrine organs. WHO classification of tumours, 1st edn. IARC Press, Lyon
van Eeden S, de Leng WWJ, Offerhaus GJA, Morsink FH, Weterman MAJ, De Krijger RR, Klöppel G, Klimstra DS (2004) Ductuloinsular tumors of the pancreas. Endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol 28:813–820
Yamaguchi K, Enjoji M (1992) Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks. Jpn J Surg 22:305–312
Acknowledgements
We would like to thank Maike Pacena and Anja Bredtmann for their excellent technical assistance, Dr. Nadir Arican for help with the statistics, and Kay Dege for editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapran, Y., Bauersfeld, J., Anlauf, M. et al. Multihormonality and entrapment of islets in pancreatic endocrine tumors. Virchows Arch 448, 394–398 (2006). https://doi.org/10.1007/s00428-005-0147-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-005-0147-4